Yili Chuanning Biotechnology Co.,Ltd.

301301

CNE100005WX0

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2024-09-13			5-day change	1st Jan Change
10.62 ^CNY	-1.21%		-1.21%	+26.43%

Aug. 26	Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
Jul. 11	Yili Chuanning Biotechnology Gets Nod to Market Ursodeoxycholic Acid	MT

Yili Chuanning Biotechnology Co.,Ltd. Approves Cash Dividend for the Year 2023

May 14, 2024 at 03:34 pm EDT

Yili Chuanning Biotechnology Co.,Ltd. held its Annual General Meeting of 2023 on 13 May 2024, approved cash dividend (tax included) of CNY 2.25000000 per ten shares for the year 2023.

Latest news about Yili Chuanning Biotechnology Co.,Ltd.

Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	Aug. 26	CI
Yili Chuanning Biotechnology Gets Nod to Market Ursodeoxycholic Acid	Jul. 11	MT
Yili Chuanning Biotechnology Co.,Ltd. Approves Cash Dividend for the Year 2023	May. 14	CI
Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 21	CI
Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 10	CI
Yili Chuanning Biotechnology Signs Cooperation Deal With Jinhui Technology	Feb. 23	MT
Certain A Shares of Yili Chuanning Biotechnology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 27-DEC-2023.	Dec. 26	CI
Yili Chuanning Biotechnology Co.,Ltd.(SZSE:301301) added to Shenzhen Stock Exchange Component Index	Dec. 12	CI
Yili Chuanning Biotechnology Co.,Ltd.(SZSE:301301) added to Shenzhen Stock Exchange Component A Share Index	Dec. 12	CI
Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
Yili Chuannig Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21	CI
Yili Chuannig Biotechnology Co., Ltd.(XSEC:301301) added to S&P Global BMI Index	23-06-19	CI
Yili Chuannig Biotechnology Co., Ltd. Implements Final Cash Dividend on A Shares for 2022, Payable on 29 May 2023	23-05-22	CI
Yili Chuannig Biotechnology Co., Ltd. Approves Directorate Appointments	23-05-08	CI
Yili Chuannig Biotechnology Co., Ltd. Approves Final Cash Dividend for 2022	23-05-08	CI
Yili Chuannig Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Yili Chuannig Biotechnology Co., Ltd. Proposes Final Cash Dividend for 2022	23-04-03	CI
Shanghai Ruikang Biotechnology R&D Co., Ltd. announced that it expects to receive CNY 100 million in funding from Yili Chuannig Biotechnology Co., Ltd.	23-03-30	CI
Yili Chuannig Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-12	CI
Yili Chuannig Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-12-06	CI

Chart Yili Chuanning Biotechnology Co.,Ltd.

Duration

Period

Chart Yili Chuanning Biotechnology Co.,Ltd.

More charts

Yili Chuanning Biotechnology Co Ltd is a China-based company mainly engaged in the research, development and industrialization of biological fermentation technology. The Company's products mainly include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, crude ursodeoxycholic acid, coenzyme Q10 mycelium and others. The Company's products are mainly exported to countries such as India.

Employees

2,881

Sector

Pharmaceuticals

Calendar

2024-10-21 - Q3 2024 Earnings Release (Projected)

More about the company